Whole-genome analysis informs breast cancer response to aromatase inhibitionMatthew J. Ellis, Mark A. Watson, Li Ding et al.|Nature|2012Cited by 1k
Genetic/Familial High-Risk Assessment: Breast and OvarianMary B. Daly, Jeffrey N. Weitzel, Heather Hampel et al.|Journal of the National Comprehensive Cancer Network|2010Cited by 650
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015Mary B. Daly, Susan Darlow, Robert Pilarski et al.|Journal of the National Comprehensive Cancer Network|2016Cited by 293
Combination mTORC1/2 and BCL- X<sub>L</sub> inhibition in endocrine and CDK4/6-resistant estrogen receptor-positive breast cancer.Sarah Sammons, Kris C. Wood, Grace R. Anderson et al.|Journal of Clinical Oncology|2019Cited by 2